Clinical Trials
These studies welcome inquiries from patients as well as physicians. Studies include research on diseases of the heart and blood vessels, lungs, blood cells and bone marrow, and cholesterol. Qualified patients will receive free evaluation and treatment.
Patients with type 2 diabetes mellitus die of cardiovascular disease (CVD) at rates two to four times higher than non-diabetic populations of similar demographic characteristics.
All clicical trials have guidelines about who can participate. The factors that allow someone to participate in a clinical trial are called "inclusion criteria" and those that disallow someone from participating are called "exclusion criteria". It is important to note that inclusion and exclusion criteria are not used to reject people personally. Instead the criteria are used to identigy appropriate participants and keep them safe.
ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.
In the HF-ACTION trial, a team of well-known doctors throughout the U.S. and Canada is working with the National Heart, Lung, and Blood Institute (NHLBI), part of the Federal Government’s National Institutes of Health (NIH), to determine whether exercise can reduce mortality and hospitalizations for patients with heart failure.
We conduct a large number of research studies with patients who have diseases of the heart and blood vessels, lungs, blood cells and bone marrow, or cholesterol.
Many drugs have been developed in recent years to treat high blood pressure (or hypertension) and high cholesterol, two major risk factors for heart disease. Recent findings from ALLHAT—the "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial"—a major clinical study supported by the National Heart, Lung, and Blood Institute (NHLBI), offer new information about treating both conditions.
The WHI was launched in 1991 and consisted of a set of clinical trials and an observational study, which together involved 161,808 generally healthy postmenopausal women.
The clinical trials were designed to test the effects of postmenopausal hormone therapy, diet modification, and calcium and vitamin D supplements on heart disease, fractures, and breast and colorectal cancer.
This website presents information about NIH-supported research to facilitate progress towards obesity prevention and treatment. Through its research mission, the NIH seeks to identify genetic, behavioral, and environmental causes of obesity; to understand how obesity leads to type 2 diabetes, cardiovascular disease, and other serious health problems; and to build on basic and clinical research findings to develop and study innovative prevention and treatment strategies.
Pages: 1
